IP Verse

Hikma Pharmaceuticals USA Inc. et al. v. Amarin Pharmaceuticals Ireland Limited - IPR2022-00215

Explore the PTAB proceeding IPR2022-00215 filed by Hikma Pharmaceuticals USA Inc. et al. against Amarin Pharmaceuticals Ireland Limited on Nov 30, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2022-00215
Filing Date
Nov 30, 2021
Petitioner
Hikma Pharmaceuticals USA Inc. et al.
Respondent
Amarin Pharmaceuticals Ireland Limited
Status
Terminated-Settled
Respondent Application Number
13768906
Respondent Tech Center
1600
Respondent Patent Number
8642077
Termination Date
Mar 14, 2022

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2022-00215.

TypeName
Petitioner CounselWong, Jovialet al
Respondent CounselFournier, Davidet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.